Article No
CP152-50MG
RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus
RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus
Antibodies Isotype Control
Specifications
| MW | 150 kDa |
| Application | FA |
| Article No | CP152-50MG |
| Country Availability | SE, FI, DK, NO, EE, LV, LT |
| Clone | Palivizumab-CP152 |
| Clone Type | monoclonal |
| Concentration | 4-11 mg/ml |
| Conjugation | Unconjugated |
| Description | RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus |
| Supplier | BioXCell |
| Endotoxin | <1EU/mg (<0.001EU/µg), Determined by LAL gel clotting assay|RecombiMAb |
| Isotype | IgG4 k |
| Product Type | Antibodies Isotype Control |
| Purity | >95% |
| Shipping Information | BLUE ICE |
| Size | 50 mg |
| Source / Host | human |
| Species Reactivity | virus |
| Storage | 4°C |
| Product Page Updated | 2024-03-25T10:15:09.827Z |
